Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 5/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALPG | P10696 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466096 | 1.00 | MEN1 (0.43) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL610013 | 1.00 | MEN1 (0.43) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL14399560 | 0.86 | MEN1 (0.41) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL27100749 | 0.84 | MEN1 (0.47) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL17342555 | 0.84 | SNCA (0.45) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL23702608 | 0.82 | MAPK1 (0.41) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL27100756 | 0.82 | MEN1 (0.51) | MEN1KMT2AMAPTGFERALDH1A1 | |
| SCHEMBL17342556 | 0.81 | NPSR1 (0.43) | MEN1KMT2AMAPTALDH1A1L3MBTL1 | |
| SCHEMBL16270944 | 0.81 | GAA (0.36) | MEN1KMT2AMAPTHIF1AEPAS1 | |
| SCHEMBL19000228 | 0.80 | HTR2C (0.40) | MEN1KMT2AMAPTHTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600879-B2 | Coated lens and method for manufacturing the same | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2026-04-14 | — | — | US | disclosed |
| EP-4493966-A2 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | Carl Zeiss Vision International GmbH (DE) | 2025-01-22 | — | — | EP | disclosed |
| US-20240417588-A1 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2024-12-19 | — | — | US | disclosed |
| EP-3488287-B1 | PRINTING INK, PREFERABLY 3D PRINTING INK, SPECTACLE LENS, AND METHOD FOR MANUFACTURING AN EYEGLASS LENS | ZEISS CARL VISION INT GMBH (DE) | 2023-12-20 | — | — | EP | disclosed |
| WO-2023175193-A2 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2023-09-21 | — | — | WO | disclosed |
| CN-113801299-B | Fluorescent conjugated polymer containing spiropyran side group, preparation method and application | 苏州大学 | 2022-06-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600879-B2 | Coated lens and method for manufacturing the same | GMFG, AQP4, METTL14 | MEN1 339/4885KMT2A 1607/4885MAPT 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.